• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Advancing cardiovascular risk assessment: Real-time SCORES2 calculation through CDSS in primary care patients.

作者信息

Salinas M, Flores E, Ahumada M, Leiva-Salinas M, Blasco A, Leiva-Salinas C

机构信息

Clinical Laboratory, Hospital Universitario de San Juan, San Juan de Alicante, Spain.

Clinical Laboratory, Hospital Universitario de San Juan, San Juan de Alicante, Spain; Department of Clinical Medicine, Universidad Miguel Hernandez, Elche, Spain.

出版信息

Clin Biochem. 2025 Jun;137:110922. doi: 10.1016/j.clinbiochem.2025.110922. Epub 2025 Apr 17.

DOI:10.1016/j.clinbiochem.2025.110922
PMID:40250522
Abstract

BACKGROUND

Individualized cardiovascular risk stratification is recommended to guide treatment. The objective was to report the 10-year cardiovascular disease (CVD) risk in primary care patients without previous CVD or diabetes using the SCORE2 risk prediction algorithms, SCORE2 (age 40-69 years), and SCORE2-OP (age 70-89 years) scales, as per the European Society of Cardiology guidelines. The risk levels were categorized as low-moderate (<5 %), high (5-10 %), or very high (>10 %), with recommendations for treatment, through the clinical decision support system (CDSS).

METHODS

A cross-sectional study was designed in collaboration with general practitioners. The CDSS, integrated with computerized patient order entry, facilitated the calculation for CVD-free individuals after electronic medical record consultation. We counted the patients offered SCORES calculation, the number of acceptances and calculations, the results obtained, risk factors, along with adherence to recommended treatment.

RESULTS

SCORES were offered to 971 patients, 635 SCORE2 and 336 SCORE2-OP, and 614 (96.7 %) SCORE2 and 160 (47.6 %). SCORE2-OP calculations were accepted, showing a significantly different acceptance rate. There was a significantly higher prevalence of smoking habit (P < 0.01) and hypertension (P < 0.01) among SCORE2 patients. Half of the SCORE2 patients were classified as low risk, more than 80 % of SCORE2-OP as high or very high risk. The adherence to treatment recommendations was 90.4 % overall, with a significant difference between SCORE2 (93.9 %) and SCORE2-OP (74.0 %) (P < 0.01).

CONCLUSION

The laboratory, in collaboration with clinicians and utilizing CDSS, plays a central role in clinical decision-making by reporting SCORE2 risk prediction algorithms and treatment recommendations.

摘要

相似文献

1
Advancing cardiovascular risk assessment: Real-time SCORES2 calculation through CDSS in primary care patients.
Clin Biochem. 2025 Jun;137:110922. doi: 10.1016/j.clinbiochem.2025.110922. Epub 2025 Apr 17.
2
[Cardiovascular risk assessment among patients with hypertension based on SCORE2 and SCORE-OP algorithms in black Africans].基于SCORE2和SCORE-OP算法对非洲裔高血压患者进行心血管风险评估
Ann Cardiol Angeiol (Paris). 2023 Jun;72(3):101602. doi: 10.1016/j.ancard.2023.101602. Epub 2023 May 13.
3
Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP.包括衡量慢性肾脏病的措施,以改善 SCORE2 和 SCORE2-OP 的心血管风险预测。
Eur J Prev Cardiol. 2023 Jan 11;30(1):8-16. doi: 10.1093/eurjpc/zwac176.
4
Evaluation of Cardiometabolic Risk in Patients with Non-Functioning Adrenal Adenomas Using the Systematic Coronary Risk Evaluation 2 (SCORE2) and the Systematic Coronary Risk Evaluation 2-Older Persons (SCORE2-OP) Algorithms.使用系统性冠状动脉风险评估 2 (SCORE2)和系统性冠状动脉风险评估 2-老年人(SCORE2-OP)算法评估无功能性肾上腺腺瘤患者的心脏代谢风险。
Med Sci Monit. 2024 Nov 27;30:e945899. doi: 10.12659/MSM.945899.
5
Validation of Systematic Coronary Risk Evaluation 2 (SCORE2) and SCORE2-Older Persons in the EPIC-Norfolk prospective population cohort.系统性冠状动脉风险评估 2 (SCORE2)和 SCORE2-老年人在 EPIC-Norfolk 前瞻性人群队列中的验证。
Eur J Prev Cardiol. 2024 Jan 25;31(2):182-189. doi: 10.1093/eurjpc/zwad318.
6
Predicting cardiovascular morbidity and mortality with SCORE2 (OP) and Framingham risk estimates in combination with indicators of biological ageing.结合生物学衰老指标,用SCORE2(OP)和弗雷明汉姆风险评估预测心血管疾病的发病率和死亡率。
Age Ageing. 2025 Mar 28;54(4). doi: 10.1093/ageing/afaf075.
7
Cardiovascular Risk Assessment and Control in Outpatients Evaluated by 24-hour Ambulatory Blood Pressure and Different LDL-C Equations.门诊患者 24 小时动态血压和不同 LDL-C 方程评估的心血管风险评估和控制。
High Blood Press Cardiovasc Prev. 2023 Nov;30(6):551-560. doi: 10.1007/s40292-023-00605-1. Epub 2023 Oct 30.
8
Cardiovascular risk assessment in Portugal's primary health care system: SCORE vs. SCORE2.葡萄牙初级卫生保健系统中心血管风险评估:SCORE 与 SCORE2。
Rev Port Cardiol. 2024 Aug;43(8):449-455. doi: 10.1016/j.repc.2023.10.012. Epub 2024 Feb 21.
9
[Cardiovascular risk stratification: from algorithms to clinical phenotype].[心血管风险分层:从算法到临床表型]
G Ital Cardiol (Rome). 2025 Jan;26(1 Suppl 2):e1-e5. doi: 10.1714/4425.44224.
10
Cardiovascular risk assessment using SCORE2 in a population with hypertension - The reality at a primary health care unit.应用 SCORE2 对高血压人群进行心血管风险评估 - 基层医疗单位的实际情况。
Rev Port Cardiol. 2024 Nov;43(11):601-610. doi: 10.1016/j.repc.2024.03.007. Epub 2024 Jul 14.